OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The GPR35 expression pattern is associated with overall survival in male patients with colorectal cancer
Tomasz Mackiewicz, Damian Jacenik, Marcin Talar, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 4, pp. 709-717
Closed Access | Times Cited: 7
Tomasz Mackiewicz, Damian Jacenik, Marcin Talar, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 4, pp. 709-717
Closed Access | Times Cited: 7
Showing 7 citing articles:
GPR35: from enigma to therapeutic target
Graeme Milligan
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 5, pp. 263-273
Open Access | Times Cited: 17
Graeme Milligan
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 5, pp. 263-273
Open Access | Times Cited: 17
Increased GPR35 expression in human colorectal and pancreatic cancer samples: A preliminary clinical validation of a new biomarker
Tomasz Mackiewicz, Jakub Włodarczyk, Marta Zielińska, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 32, Iss. 7, pp. 783-789
Open Access | Times Cited: 7
Tomasz Mackiewicz, Jakub Włodarczyk, Marta Zielińska, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 32, Iss. 7, pp. 783-789
Open Access | Times Cited: 7
Recent advances in GPR35 pharmacology; 5-HIAA serotonin metabolite becomes a ligand
Dong‐Soon Im
Archives of Pharmacal Research (2023) Vol. 46, Iss. 6, pp. 550-563
Closed Access | Times Cited: 5
Dong‐Soon Im
Archives of Pharmacal Research (2023) Vol. 46, Iss. 6, pp. 550-563
Closed Access | Times Cited: 5
GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells
Wuxiyar Otkur, Xiaolong Liu, Huan Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Wuxiyar Otkur, Xiaolong Liu, Huan Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
From orphan to oncogene: The role of GPR35 in cancer and immune modulation
Simran Takkar, Gunjan Sharma, Jyoti Kaushal, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 77, pp. 56-66
Closed Access | Times Cited: 1
Simran Takkar, Gunjan Sharma, Jyoti Kaushal, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 77, pp. 56-66
Closed Access | Times Cited: 1
The power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer therapy
Donato Inverso, Carlotta Tacconi, Serena Ranucci, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 12
Open Access
Donato Inverso, Carlotta Tacconi, Serena Ranucci, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 12
Open Access
Biased constitutive signalling of the G protein-coupled receptor GPR35 suppresses gut barrier permeability
Tezz Quon, Li‐Chiung Lin, Amlan Ganguly, et al.
Journal of Biological Chemistry (2024), pp. 108035-108035
Open Access
Tezz Quon, Li‐Chiung Lin, Amlan Ganguly, et al.
Journal of Biological Chemistry (2024), pp. 108035-108035
Open Access
